dr oz semaglutide Opinion Dr. Oz predicts oral weight
Description
Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, et al
Combining them doubles the GLP-1 stimulation without the benefit of the unique GIP activation advantage tirzepatide provides
Studies done on obese mice show that GIP may help burn more energy and reduce fat build-up
And with decreased appetite, what you eat matters more than ever
The combination of GLP-1 receptor agonists and DPP-4 inhibitors is not recommended, not due to safety issues, but since a clinically significant additional benefit is not expected (see below) (7072)
Stricker EM
